The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.
Open accessAbstract
Meth-A sarcoma cells were stable transfected to overexpress (sense construct) or underexpress (antisense construct) tissue factor. In vitro, there was no difference in plating efficiency or growth between these cell lines. In vivo, tumor cells transfected to overexpress tissue factor grew more rapidly, and established larger and more vascularized tumors than control transfectants. Antisense transfectants grew the slowest and were the least vascularized. Anticoagulation of mice with warfarin did not alter the difference between these tumor lines. Tumor cells over-expressing tissue factor released more (compared with control transfectants) mitogenic activity for endothelial cells in parallel with enhanced transcription of vascular permeability factor/vascular endothelial cell growth factor (VEGF/VPF), and diminished transcription of thrombospondin (TSP2), a molecule with anti-angiogenic properties. Antisense tissue factor transfectants, while releasing the lowest amount of mitogenic activity, had increased thrombospondin and decreased VEGF/VPF transcription compared with control transfectants or wild-type cells. Experiments with these sense, antisense, truncated sense, or vector tumor lines gave comparable results in complete medium, serum free medium or in the presence of hirudin, indicating that the activation of the coagulation mechanism was not likely to be responsible for changes in tumor cell properties. These results suggest that tissue factor regulates angiogenic properties of tumor cells by altering the production of growth regulatory molecules of endothelium by a mechanism distinct from tissue factor activation of the coagulation mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Self-citationTumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Drake, T. A., Morrissey, J. H., & Edgington, T. S. (1989) · Europe PMC (PubMed Central) · Cited by 1,192
Breier, G., Albrecht, U., Sterrer, S., & Risau, W. (1992) · Development · doi:10.1242/dev.114.2.521 · Cited by 1,087
Cited by
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
Self-citationBingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J., & Risau, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17629 · Cited by 836
Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, L., Demunck, H., Kasper, M., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
Self-citationThe Hypercoagulable State of Malignancy: Pathogenesis and Current Debate
Caine, G. J., Stonelake, P. S., Lip, G. Y. H., & Kehoe, S. T. (2002) · Neoplasia · doi:10.1038/sj.neo.7900263 · Cited by 576
Yu, J. L., May, L., Lhotak, V., Shahrzad, S., Shirasawa, S., Weitz, J. I., Coomber, B. L., Mackman, N., & Rak, J. W. (2005) · Blood · doi:10.1182/blood-2004-05-2042 · Cited by 570
Moberg, L., Johansson, H., Lukinius, A., Berne, C., Foss, A., Källen, R., Østraat, Ø., Salmela, K., Tibell, A., Tufveson, G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12020-4 · Cited by 568
Contrino, J., Hair, G., Kreutzer, D. L., & Rickles, F. R. (1996) · Nature Medicine · doi:10.1038/nm0296-209 · Cited by 539
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation
Kannemeier, C., Shibamiya, A., Nakazawa, F., Trusheim, H., Ruppert, C., Markart, P., Song, Y., Tzima, E., Kennerknecht, E., Niepmann, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608647104 · Cited by 535
Vascular development: cellular and molecular regulation
Beck, L., & D'Amore, P. A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141503 · Cited by 519
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Steffel, J., Lüscher, T. F., & Tanner, F. C. (2006) · Circulation · doi:10.1161/circulationaha.105.567297 · Cited by 456
Role of Tissue Factor in Cancer
Kasthuri, R. S., Taubman, M. B., & Mackman, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6324 · Cited by 412
Cell biology of tissue factor, the principal initiator of blood coagulation
Camerer, E., Kolstø, A.-B., & Prydz, H. (1996) · Thrombosis Research · doi:10.1016/0049-3848(95)00209-x · Cited by 408
Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer
Khorana, A. A., Ahrendt, S. A., Ryan, C. K., Francis, C. W., Hruban, R. H., Hu, Y. C., Hostetter, G., Harvey, J., & Taubman, M. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2351 · Cited by 394
Cancer and the prothrombotic state
Lip, G. Y., Chin, B. S., & Blann, A. D. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00619-2 · Cited by 378
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
Mathematical modeling of tumor-induced angiogenesis
Mantzaris, N. V., Webb, S., & Othmer, H. G. (2004) · Journal of Mathematical Biology · doi:10.1007/s00285-003-0262-2 · Cited by 362
The relationship between tissue factor and cancer progression: insights from bench and bedside
van den Berg, Y. W., Osanto, S., Reitsma, P. H., & Versteeg, H. H. (2012) · Blood · doi:10.1182/blood-2011-06-317685 · Cited by 354
Molecular Basis for the Relationship Between Thrombosis and Cancer
Rickles, F. R., & Falanga, A. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00285-7 · Cited by 329
Inhibition of tissue factor signaling suppresses tumor growth
Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., & Ruf, W. (2008) · Blood · doi:10.1182/blood-2007-07-101048 · Cited by 327
Abe, K., Shoji, M., Chen, J., Bierhaus, A., Danave, I., Micko, C., Casper, K., Dillehay, D. L., Nawroth, P. P., & Rickles, F. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8663 · Cited by 312
Self-citationOtt, I., Fischer, E. G., Miyagi, Y., Mueller, B. M., & Ruf, W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1241 · Cited by 301
DVORAK, H. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01361.x · Cited by 296
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.
Bromberg, M. E., Konigsberg, W. H., Madison, J. F., Pawashe, A., & Garen, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8205 · Cited by 295
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
Smorenburg, S. M., & Van Noorden, C. J. F. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01481-9 · Cited by 294
Protease-activated receptor 2 signaling in inflammation
Rothmeier, A. S., & Ruf, W. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0289-1 · Cited by 289
Targeted disruption of the murine tissue factor gene results in embryonic lethality
Toomey, Jr., Kratzer, K., Lasky, N., Stanton, J., & Broze, G. J. (1996) · Blood · doi:10.1182/blood.v88.5.1583.1583 · Cited by 279
Pancreatic cancer and thromboembolic disease
Khorana, A. A., & Fine, R. L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01606-7 · Cited by 269
Tissue factor expression and prognosis in patients with metastatic prostate cancer
Akashi, T., Furuya, Y., Ohta, S., & Fuse, H. (2003) · Urology · doi:10.1016/s0090-4295(03)00768-4 · Cited by 75
Expression of Tissue Factor in Prostate Cancer Correlates With Malignant Phenotype
Kaushal, V., Mukunyadzi, P., Siegel, E. R., Dennis, R. A., Johnson, D. E., & Kohli, M. (2008) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/01.pai.0000213157.94804.fc · Cited by 32
Metadata
- Authors
- Zhang, Y., Deng, Y., Luther, T., Müller, M., Ziegler, R., Waldherr, R., Stern, D. M., & Nawroth, P. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-09-01
- Volume
- 94
- Issue
- 3
- Pages
- 1320-1327
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1984352482
- Cited by
- 481
- References
- 29
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.